Skip to main content
. 2024 Mar 27;24:120. doi: 10.1186/s12871-024-02504-x

Table 3.

MAP (mmHg) follow-up in the two study groups

MAP (mmHg) Group D (n = 64) Group C (n = 64) 95% CI P
Basal 95.89 ± 6.515 94.98 ± 6.975 -1.45, 3.27 0.449
10 min 94.58 ± 8.587 92.83 ± 10.542 -1.62, 5.12 0.305
20 min 96.19 ± 9.053 92.64 ± 11.707 -0.11, 7.21 0.057
30 min 95.64 ± 9.918 93.08 ± 11.871 -1.26, 6.39 0.187
45 min 95.74 ± 9.495 92.49 ± 11.267 -1.17, 7.67 0.148
60 min 96.55 ± 8.319 91.63 ± 10.730 -0.61, 10.43 0.080

Data are presented as mean ± standard deviation

Group D Patients injected with dexmedetomidine plus lidocaine/ epinephrine), group C Patients injected only with lidocaine/ epinephrine